Clinical trials in progress

Pemphigus vulgaris

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Massachusetts, USA

CellCeptĀ® (Mycophenolate Mofetil) in Pemphigus Vulgaris
British Columbia, Canada

Effect of Anti CD20 in Pemphigus
Rouen, France

Use of Infliximab for the Treatment of Pemphigus Vulgaris
Florida, North Carolina, Pennsylvania, Wisconsin

Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin
Northwestern University


Rituximab in the Treatment of Patients With Bullous Pemphigoid
Duke University, North Carolina

Other studies

Mucous membrane pemphigoid

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
National Institute of Health, USA

Immune Responses to Antigens in Non-Infectious Eye Inflammatory Diseases
National Eye Institute, USA

Linear IgA bullous disease